Publicacions en què col·labora amb Vicente Balanzá Martínez (19)

2021

  1. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

    Revista de Psiquiatria y Salud Mental

  4. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2019

  1. "readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness

    European Addiction Research, Vol. 25, Núm. 5, pp. 256-262

2018

  1. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  2. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

  2. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  3. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  4. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

  5. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

    European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264

  2. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study

    Schizophrenia Research, Vol. 164, Núm. 1-3, pp. 65-73

2014

  1. Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder

    Journal of Affective Disorders, Vol. 160, pp. 50-54

2013

  1. Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study

    American Journal of Psychiatry, Vol. 170, Núm. 8, pp. 852-859